Disrupting In-vitro Diagnostics: Solving the Business Model vs. Technology Innovation Dilemma

December 24, 2015 | State of the Market Report

Growing populations, increasing incidence/prevalence rates of chronic diseases, and development of new tests are fueling the growth of the clinical laboratory testing market dominated by large independent and hospital-based centralized labs. We identify and analyze paths to the key U.S. market for companies looking to enter the clinical testing market and capitalize on its growth.

Coverage Areas

  • Consumer Choices in Food, Health, and Wellness
  • Digital Health and Wellness
  • Digital Transformation

Table of Contents

  • Title page
  • Executive summary
  • Contents
  • Landscape
  • Analysis
  • Outlook

Lead Analyst

Milos Todorovic
Analyst

Contributors

Jonathan Melnick, Ph.D.
Kevin Pang, Ph.D., M.B.A.

Login to View This Research

Already a Lux Client?

Sign In

Not a Lux Client?

Talk to Lux Research now and learn the benefits of becoming a member.

Lux Research

  • Helps clients find new business opportunities from emerging technologies in the physical and life sciences
  • Offers ongoing technology and market intelligence, as well as market data and consulting services
  • Now serves over 250 clients on six continents – multinational corporations, investors, governments, and SMEs
  • Has a Global reach, with offices in Boston, New York, Amsterdam, Singapore, and Tokyo
  • Combines deep technical expertise with business analysis to support strategic decisions

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 (0) 20-3460840

For APAC (Singapore)
+65 6592-6978